GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,616,878 | -34.0% | 690,469 | -4.2% | 0.00% | 0.0% |
Q2 2023 | $3,965,248 | +33.7% | 720,954 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $2,965,018 | -5.9% | 689,539 | -14.0% | 0.00% | 0.0% |
Q4 2022 | $3,151,841 | -27.2% | 801,995 | -1.7% | 0.00% | 0.0% |
Q3 2022 | $4,330,000 | +208.8% | 815,576 | +281.8% | 0.00% | – |
Q2 2022 | $1,402,000 | -6.9% | 213,622 | +4.1% | 0.00% | – |
Q1 2022 | $1,506,000 | +199.4% | 205,168 | +189.0% | 0.00% | – |
Q4 2021 | $503,000 | -94.3% | 70,990 | -79.7% | 0.00% | -100.0% |
Q3 2021 | $8,750,000 | -14.1% | 349,034 | -7.8% | 0.00% | 0.0% |
Q2 2021 | $10,185,000 | -31.7% | 378,623 | -27.8% | 0.00% | -50.0% |
Q1 2021 | $14,923,000 | +217.1% | 524,356 | +215.9% | 0.00% | +300.0% |
Q4 2020 | $4,706,000 | +1928.4% | 165,985 | +2107.0% | 0.00% | – |
Q3 2020 | $232,000 | -79.0% | 7,521 | -85.7% | 0.00% | – |
Q2 2020 | $1,105,000 | – | 52,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
Corton Capital Inc. | 15,493 | $102,000 | 0.10% |